U.S.-based biotechnology company Bio-Path Holdings Inc announced that it is launching an $18.5 million share offering.

Bio-Path Holdings has agreed to divest nearly 713,000 shares of common stock set at $25.95 apiece.

Bio-Path Holdings will use the net funds to support its working capital and general corporate purposes.

The share offering is expected to be completed on March 14.